Xiyang Biotechnology
Kunming
About Xiyang Biotechnology
Xiyang Biotechnology is an innovative biotech company that specializes in the development of peptide-based drugs for neurological systemic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $703.5K
- Funding stage: Seed
- Last round: Seed (Jan 2024)
Industries & Categories
Biopharma, Biotechnology, Neuroscience
Canonical: https://fsome.com/organization/xiyang-biotechnology-177951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.